November 17, 2009
IDEV TECHNOLOGIES NAMES CHRISTOPHER M. OWENS PRESIDENT, CHIEF EXECUTIVE OFFICER

March 18, 2009
IDEV TECHNOLOGIES ANNOUNCES FIRST PATIENT ENROLLED IN MULTI-CENTER CLINICAL TRIAL OF SUPERA PERIPHERAL STENT

March 18, 2009
U.S. FOOD AND DRUG ADMINISTRATION CLEARS WAY FOR MULTICENTER CLINICAL TRIAL OF IDEV TECHNOLOGIES SUPERA PERIPHERAL STENT

January 31, 2008
IDEV Technologies Inc. Receives 510(k) Clearance for New SUPERA Biliary Stent Delivery Catheter

November 28, 2006
IDev Technologies, Inc. closes $19 Million Financing

August 8, 2006
IDev Technologies, Inc. Gains a 510(k) Clearance for its Interwoven Nitinol Self-Expanding Stent for Palliative Treatment of Malignant Strictures in the Biliary Tree. 

May 4, 2006
IDev Technologies, Inc. Announces the Hiring of a New Executive Management Team

May 3, 2006
IDev Technologies, Inc. Gains CE Mark Approval for New Nitinol Stent in Peripheral Vascular Disease


All media inquiries should be directed to Christopher M. Owens, President and CEO, IDev Technologies, Inc., (281)333-1998

Photo Gallery, Company Logo, and Press Media Kit Access Area